Near-infrared fluorescence imaging platform for quantifying in vivo nanoparticle diffusion from drug loaded implants

International Journal of Nanomedicine

Volumn 11, Issue , 2016, Pages 1213-1223

  Markovic, Stacey ^a   Belz, Jodi ^a   Kumar, Rajiv ^b,c   Cormack, Robert A ^c   Sridhar, Srinivas ^b,c   Niedre, Mark ^a  

^a Northeastern University   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Brachytherapy; Drug delivery; Fluorescence; Optical imaging; Treatment monitoring

Indexed keywords

NANOPARTICLE; POLYGLACTIN; DRUG IMPLANT;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL ANALYSIS; CHEMORADIOTHERAPY; DRUG DELIVERY SYSTEM; DRUG IMPLANT; FLUORESCENCE IMAGING; IN VIVO STUDY; MALE; MOLECULAR IMAGING; MOUSE; NEAR INFRARED IMAGING SYSTEM; NONHUMAN; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; PROCESS OPTIMIZATION; RADIATION DOSE; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; VALIDATION STUDY; ANIMAL; CHEMISTRY; DIFFUSION; FLUORESCENCE; IMAGING PHANTOM; NEAR INFRARED SPECTROSCOPY; NUDE MOUSE; PROCEDURES;

ANIMALS; DIFFUSION; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; FLUORESCENCE; MICE; MICE, NUDE; NANOPARTICLES; OPTICAL IMAGING; PARTICLE SIZE; PHANTOMS, IMAGING; SPECTROSCOPY, NEAR-INFRARED;

EID: 84962077057     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S93324     Document Type: Article

References (25)

1. Implants in Drug Delivery. In: Ranade VV, Cannon JB, editors. Drug Delivery Systems. 3rd ed. Boca Raton, Florida: CRC Press; 2011.
2. Chang-Lin JE, Attar M, Acheampong AA, et al. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci. 2011;52(1):80-86.
3. Cormack RA, Sridhar S, Suh WW, D’Amico AV, Makrigiorgos GM. Biological in situ dose painting for image-guided radiation therapy using drug-loaded implantable devices. Int J Radiat Oncol Biol Phys. 2010;76(2):615-623.
4. Friedland JL, Freeman DE, Masterson-McGary ME, Spellberg DM. Stereotactic body radiotherapy: an emerging treatment approach for localized prostate cancer. Technol Cancer Res Treat. 2009;8(5): 387-392.
5. Sylvester JE, Grimm PD, Eulau SM, Takamiya RK, Naidoo D. Permanent prostate brachytherapy preplanned technique: the modern Seattle method step-by-step and dosimetric outcomes. Brachytherapy. 2009;8(2):197-206.
6. Kumar R, Belz J, Markovic S, et al. Nanoparticle-based brachytherapy spacers for delivery of localized combined chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2015;91(2):393-400.
7. National Cancer Institute [homepage on the Internet]. Prostate Cancer Treatment (PDQ®). NIH National Cancer Institute; 2014. Available from: http://www.cancer.gov/cancertopics/pdq/treatment/prostate/Patient. Accessed December 6, 2015.
8. Tishler RB, Geard CR, Hall EJ, Schiff PB. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res. 1992;52(12): 3495-3497.
9. Castro Kreder N, Van Bree C, Franken NA, Haveman J. Effects of gemcitabine on cell survival and chromosome aberrations after pulsed low dose-rate irradiation. J Radiat Res. 2004;45(1):111-118.
10. Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol. 2003;7(5):626-634.
11. Lin Y, Weissleder R, Tung CH. Novel near-infrared cyanine fluoro-chromes: synthesis, properties, and bioconjugation. Bioconjug Chem. 2002;13(3):605-610.
12. Ghoroghchian PP, Therien MJ, Hammer DA. In vivo fluorescence imaging: a personal perspective. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1(2):156-167.
13. Kumar R, Roy I, Ohulchanskyy TY, et al. Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. ACS Nano. 2008;2(3): 449-456.
14. Kumar R, Roy I, Ohulchanskky TY, et al. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano. 2010;4(2):699-708.
15. Wang L, Wu H, Biomedical Optics: Principles and Imaging. 1st ed. Hoboken (NJ): Wiley-Interscience; 2007.
16. Chen ZJ, Gillies GT, Broaddus WC, et al. A realistic brain tissue phan- tom for intraparenchymal infusion studies. J Neurosurg. 2004;101(2): 314-322.
17. Cubeddu R, Pifferi A, Taroni P, Torricelli A, Valentini G. A solid tissue phantom for photon migration studies. Phys Med Biol. 1997;42(10): 1971-1979.
18. Pomfret R, Miranpuri G, Sillay K. The substitute brain and the potential of the gel model. Ann Neurosci. 2013;20(3):118-122.
19. Ntziachristos V, Turner G, Dunham J, et al. Planar fluorescence imaging using normalized data. J Biomed Opt. 2005;10(6):064007.
20. Crank J. The Mathematics of Diffusion. 2nd ed. New York: Oxford University Press; 1979.
21. Martin JM, Handorf EA, Kutikov A, et al. The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base. Cancer. 2014; 120(14):2114-2121.
22. American Cancer Society [homepage on the Internet]. Prostate Cancer That Remains or Recurs after Treatment. American Cancer Society; 2015. Available from: http://www.cancer.org/cancer/pros-tatecancer/detailedguide/prostate-cancer-treating-recurrence. Accessed December 6, 2015.
23. Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol. 2007; 177(6):2151-2156.
24. Zietman AL, Bae K, Slater JD, et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09. J Clin Oncol. 2010;28(7):1106-1111.
25. Kuban DA, Tucker SL, Dong L, et al. A long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70(1):67-74.